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Abstract: In this article, we review a process put for-
ward in former publications by which fatty acid 
micelles and vesicles with an acidic core can develop, 
and the physiological manifestations of such process 
in the human body. The process allows the under-
standing of arterial calcification, why coronary 
arteries, aorta, and carotids are the most affected 
vessels, and the preferential distribution of plaques 
on the areas of the endothelium where shear stress is 
lower. Also reviewed are the role of systemic buffers 
in the control of blood pH, and the effects of pollu-
tants, namely heavy metals, diet, and ethanol intake, 
on cardiovascular risks. The most important cardio-
vascular risk factors are explained based on their 
effect on either lowering blood pH or increasing 
blood FFA concentration, or both. Cardiovascular 
risk protection factors also find an explanation with-
in the proposed framework. As a final point, the 
importance of knowing blood pH and concentra-
tions of free fatty acids and albumin concentrations 
in the blood is emphasized in developing a strategy 
of prevention of cardiovascular disease. [Discovery 
Medicine 28(154):1-6, 2019]
Introduction
For decades, lowering low-density lipoprotein choles-
terol (LDL-C) to circumvent cardiovascular disease
(CVD) has been the cornerstone of preventive cardiol-
ogy. However, the cholesterol hypothesis has a reduced
explanatory capacity regarding the understanding of the
multiple manifestations of cardiovascular disease
(DuBroff, 2018). Consequently, from time to time,
some researchers call for a reappraisal, or turn their
attention back to other actors considered to be implicat-
ed in CVD, such as triglycerides (Pradhan, 2019). On
the other hand, understanding of the acute events
(myocardial infarction, stroke, sudden cardiac death)
based only on the idea of occlusion of arteries proves to
be very difficult and complicated (Rothberg, 2013).
In recently published articles (Reis, 2016; 2017), it was
put forward a new framework for the development of
CVD in which major cardiovascular risks could be eas-
ily understood. In addition, that framework allows us to
understand the clinical manifestation that is characteris-
tic of each acute cardiovascular event.
In this paper, we add further evidence and broaden our
understanding of other CVD risks within the proposed
framework.
New Framework for the Understanding of
Cardiovascular Disease
Fatty acids (FA) are one of the most important sources 
of energy in the body. Compared to the same amount of 
glucose, they produce about 2.5 times more energy. It is 
therefore a high-quality fuel that is used on special 
occasions (e.g., fight or fly), which plays a very impor-
tant role in human physiology (Newsholme and Leech,
2010).
An interesting fact is that fatty acids are esterified in the
liver and the adipose tissue to form triacylglycerol (also
known as triglyceride) by binding three fatty acids to a
glycerol molecule. They are then transported in the
blood by lipoproteins, namely VLDL and chylomi-
crons.
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And, there is a good reason why until FA are oxidized
in mitochondria, they are kept esterified as triglyc-
erides. In fact, when free in solution, the fatty acids
undergo phase transformations with changes in pH.
Close to normal blood pH (7.38-7.43), fatty acids are
fully protonated and form an oil phase, while at higher
pH they become deprotonated and form free fatty acid
(FFA) micelles (Wald et al., 2006; Morigaki and Wald,
2007; Zhu et al., 2013; Hentrich and Szostak, 2014).
When in the bloodstream micelles flow turbulently to a
lower pH zone, a new transformation occurs, giving
rise to fatty acid vesicles in an autocatalytic process
(Markvoort et al., 2010; Musacchio and Torchilin,
2013).
Due to deprotonation of fatty acids, vesicles formed in
alkaline conditions have an acidic core (pH partition
effect) (Chen and, Szostak, 2004; Wald et al., 2006;
Morigaki and Wald, 2007; Musacchio and Torchilin,
2013; Hentrich and Szostak, 2014). Fatty acid vesicles
easily fuse with the endothelia (Cevc and Richardsen,
1993), then deliver their acidic core, and damage ion
channels (Nilius and Droogmans, 2001) therefore dis-
turbing endothelial functioning. This is critical in the
case of the heart because damage to the cardiac
endothelium compromises myocardial function
(Brutsaert et al., 1998). Vesicle attachment may also
occur on the endothelia of the arteries. At the site of
vesicle attachment, an acid spot is created due to the
release of the acidic core, therefore, lowering local pH.
Calcium is released at this acidic spot due to loss of
affinity between albumin and calcium ions. Continued
aggression of the FA vesicles to the endothelium leads
to progressive calcification on the affected areas (Reis,
2016).
One may wonder if such changes in pH do occur in
human blood. In fact, there are very special conditions
where this can occur, as we will see in the following.
Human physiology controls blood pH very effectively
so that it is not out of the narrow range 7.38-7.43. This
control is accomplished by systemic buffers (carbonic
acid-bicarbonate system, hemoglobin, protein system,
and phosphate system), renal function, and excreting
excess acid through sweating, urine, etc. [for a more
detailed analysis see Reis (2017)].
The buffer that most quickly reacts to a pH lowering is
the carbonic acid-bicarbonate system by increasing the
respiration rate (hyperventilation) to increase carbon
dioxide release, and thereby favoring the rapid return to
normal pH levels. By increasing the release of carbon
dioxide from blood in the lungs, hyperventilation
induces local blood alkalemia, and therefore creates the
conditions needed for the development of fatty acid
micelles. Additionally, under alkaline conditions albu-
min loses affinity for fatty acids, releasing them in the
blood as FFA, while increasing affinity for calcium
whose blood concentration decreases (Newsholme and
Leech, 2010). This further increases the concentration
of FFA in the alveolar blood, an effect additionally rein-
forced by the fact that oxyhemoglobin generated in the
alveoli is a buffer for fatty acids weaker than deoxyhe-
moglobin (Thomas and Lumb, 2012).
Blood flowing from the lungs to the left atrium where
pH is lower may generate fatty acid vesicles as
described above, which may damage the inner walls of
the left atrium and ventricle, and the endothelium of
nearby arteries (namely the coronaries, the aorta, and
the carotids). The process and the occurrence of acute
events (myocardial infarction and thromboembolic
stroke) are described in detail in Reis (2016). However,
it should be noted that for fatty acid vesicles to origi-
nate, the concentration of FFA in the blood must be
high, though the threshold level is not yet known.
Another situation in which unrestrained hyperventila-
tion occurs is during intense sports practice, e.g., in bas-
ketball and soccer games. If the blood concentration of
FFA is very high and exceeds a critical ratio to albumin
concentration (see below), a process of rapid formation
of micelles and fatty acid vesicles may occur, which by
the above process can cause myocardial disturbances,
namely disruptions in electrical conduction. This might
lead to sudden cardiac death (SCD), even in the absence
of atherosclerosis. As referred by some authors
“Cardiovascular-related sudden death was the leading
cause of death in 45 (56%) of 80 medical cases, and
represented 75% of sudden deaths during exertion. …
.Data from our pathology unit demonstrate a high
prevalence of SCDs with a morphologically normal
heart (23%), with no other cause of death found at
autopsy” (Sheppard, 2012), and “Unexplained death
with a structurally normal heart is the most common
finding after suspected sudden cardiac death in NCAA
athletes” (Harmon et al., 2014).
Sudden Unexplained Nocturnal Death Syndrome
(SUNDS) might also find an explanation in the above
context, since it was noticed that “Gurgling, gasping, or
labored respirations appeared in some victims before
death” (Zheng et al., 2018). In fact, if acidemia occurs
during sleep, the fastest way to bring blood pH to nor-
mal values is by increasing the removal of CO2 through
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the acceleration of the respiratory rate, together with the
increase in urine production.
In support of the above framework, several recent
studies have associated sudden cardiac death with
high FFA levels (Pilz et al., 2007; Havmoeller et al.,
2014).
The framework presented above also allows us to
understand the symptoms that come with myocardial
infarction: “Chest discomfort or pain (feel like a tight
ache, pressure, fullness, or squeezing in the chest); pain
or discomfort may spread beyond the chest to the shoul-
ders, arms, back, neck, teeth or jaw; shortness of breath;
lightheadedness; anxiety; excessive sweating.” For a
detailed analysis, see Reis (2016). It also allows us to
understand why atherosclerotic plaques are preferen-
tially distributed through the coronary arteries, the
aorta, and the carotids, which are the vessels that first
carry left atrial and ventricular blood where fatty acid
vesicles develop (Reis, 2016). Additionally, it is possi-
ble to understand why atherosclerotic plaques in the
arteries occur in the areas where shear stress is low,
because it is precisely in those areas where the lift force
is lower, thus allowing fatty acid vesicles to attach more
easily to the endothelium (Reis, 2016).
In this context, we can also explain the occurrence of
myocardial infarction, even without the existence of
clots obstructing the coronary arteries, an aspect that
has long been observed by cardiopathologists (Baroldi
and Silver, 2004; Abdelghani et al., 2015). Yet, clots
may appear in the blood due to changes in the various
blood components owing to the presence of high con-
centrations of FFA, and then provoke arterial occlusion.
In fact, high blood FFA levels favor thromboxane for-
mation, vasoconstriction (though not all FFA do it at the
same degree), significantly elevate lipoprotein(a), acti-
vate plasminogen activator inhibitor-1 (PAI-1), and the
coagulation factors VII and XII. However, it has long
been known that platelet aggregation promoted by long-
chain saturated fatty acids only starts to be observed
when the molar ratio of FFA/albumin is greater than 2
[see Reis (2016) for details]. This explains why not
every condition in which both acidemia and FFA are
present leads to formation of fatty acid micelles and
vesicles, and clots. Nevertheless, albumin is crucial as a
fatty acid carrier, because low concentrations of albu-
min may originate a higher concentration of FFA in the
blood. Not surprisingly, a low blood albumin concentra-
tion predicts mortality, at least in nonagenarians
(Yanagisawa, 2010).
A Rationale for Cardiovascular Disease Risks
Concerning the so-called cardiovascular risks, the
above framework also provides a consistent explana-
tion. The term “cardiovascular risk” is a definition of
statistical nature, representing the set of indicators that
in a statistically significant manner were associated
with CVD. Although the statistical method detects asso-
ciations of certain indicators with CVD, it does not dis-
tinguish between those that are causal in nature and
those that are simply consequences.
Even in this context, a comprehensive explanation for
the vast majority of cardiovascular risks can be found.
In general, known risk indicators that really shape the
context for cardiovascular events originate in the body
in the form of either acidemia or a large release of FFA
in the blood, or both. Actually, because both high levels
of FFA and acidemia must come together to develop
CVD, if one of these conditions is already in place, then
the probability of the simultaneous occurrence of both
conditions and therefore of a cardiovascular event is
higher. As a result, the occurrence of either acidemia or
a high level of FFA has to be regarded as cardiovascular
risk.
Acidemia may result either from increased H+ load or to
HCO3- loss. Many drugs that disrupt the acid-base bal-
ance in the body and lower blood pH are listed as car-
diovascular risk factors. A more detailed review of
drugs that contribute to acidemia in one or the other
way may be found in Reis (2016). Particular reference
should be made to the most prescribed drugs, namely
NSAIDs (Hunter et al., 2011; Liamis et al., 2010), and
proton pump inhibitors (PPI), which contribute to lower
blood pH and have been associated with increased CVD
risk (Shah et al., 2015). PPIs block the release of acid
into stomach, therefore, reducing the body’s capability
to get rid of part of the acid load. Chronic kidney dis-
ease which leads to reduction in serum bicarbonate
(HCO3-) concentration, therefore contributing to
acidemia, is also listed a cardiovascular risk factor [see
Reis (2017) for more details].
Diets high in proteins, carbohydrates, and sugars also
contribute to the body’s acid load, while fruits and veg-
etables have an alkalinizing effect, which may explain
why they are considered as being protective against
CVD (Reis, 2017).
The systemic buffers that regulate blood pH also
decline with age and are affected by some diseases. The
carbonic acid-bicarbonate system efficiency also
decreases when lungs are affected by pollution, or by an
4
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influenza episode, factors that have been recognized as
cardiovascular risks. Aging, due to the concomitant loss
of the efficiency of the carbonic acid-bicarbonate
buffer, is itself a cardiovascular risk factor. The func-
tioning of systemic buffers may be improved with
physical exercise, therefore explaining why physical
activity is protective against CVD (Reis, 2017).
Hemoglobin, which in blood has about six times the
buffering capacity of the plasma proteins, is affected by
many diseases. Namely, sickle cell hemoglobin poly-
merizes and becomes insoluble under hypoxic condi-
tions, causing a number of structural and functional
abnormalities in affected red blood cells (Piety et al.,
2015) thereby affecting buffering capacity. It is known
that sickle cell disease increases CVD risk markedly
(Akinbami et al., 2019).
Heavy metals, namely lead and cadmium (Navas-
Acien, 2007; Lamas et al., 2016), even at a slightly ele-
vated concentration in the blood, have also been con-
sidered risk factors. Not surprisingly, both metals con-
tribute to acidemia, specifically to renal tubular acido-
sis (Haque et al., 2012; Seifter and Chang, 2017). A
causal relationship was found between lead and hyper-
tension (Navas-Acien, 2007), and the process by which
acidemia may cause peripheral hypertension was
described in Reis (2017).
In recent decades, multiple studies have pointed to FFA
as a cardiovascular risk factor (Carlsson et al., 2000;
Pirro et al., 2002; Pilz et al., 2006; Pilz et al., 2007; Pilz
and Marz, 2008; Mathewet al., 2010; Roy et al., 2013;
Havmoeller et al., 2014). FFA blood concentration may
increase in response to multiple factors, though stress
plays a major role here, since it induces physiological
changes, namely, the activation of the hypothalamic-
pituitary-adrenal axis, with mobilization of FA from the
adipose tissue. Stress has long been recognized as a
major cardiovascular risk factor. Negative psychologi-
cal stressors (death of a family member or friend, expe-
rience of an accident or disaster, anxiety, etc.) that pro-
mote the increase FFA concentrations in blood have
been implicated in CVD (Reis, 2017).
In the present framework, it is also possible to under-
stand the increase of cardiovascular risk of menopausal
women, the role of statins (they reduce the release of
FFA into blood, but contribute to pH lowering) on CVD
prevention, and the circadian distribution of occurrence
of cardiovascular events (Reis, 2017).
Interestingly, alcohol, namely light to moderate con-
sumption of red wine, has been found to be a factor pro-
tective against CVD, while moderate to heavy con-
sumption is deleterious to health (Mukamal et al.,
2010). It was found that after consumption of 38 ml of
ethanol diluted in 362 ml of water, a reduction of 35-
37% in FFA concentration occurred (Pownall et al.,
1999). This reduction is achieved in part by esterifica-
tion of FFA by ethanol, producing fatty acid ethyl
esters, which are toxic to the pancreas (Huang et al.,
2014). Concomitantly, both the cardiovascular and non-
cardiovascular mortality indexes decrease in light to
moderate drinkers but increase markedly for moderate
to heavy consumers (Klatsky, 2010). We can interpret
these results in the present context by noting that
ethanol has the positive cardiovascular effect of reduc-
ing blood FFA concentration, a beneficial effect that is
overshadowed by the generation of fatty acid ethyl
esters that increases with ethanol consumption.
Recently, results of the PESA Study pointed to
increased cardiovascular risk resulting from breakfast
skipping (Uzhova et al., 2017). This result, which is
hardly explained by the current views of CVD, finds an
easy explanation within the present framework (Reis,
2018).
Conclusions
The interplay between blood pH and blood FFA con-
centrations in the context of keeping blood pH within
the normal range offers a robust framework for explain-
ing the occurrence of atherosclerosis and its manifesta-
tions, and for the acute cardiovascular events.
Proper functioning of systemic buffers, and other sys-
tems and organs that control blood pH, is critical to pre-
venting cardiovascular disease. A diet that does not 
excessively increase the body’s acid load as well as liv-
ing with low levels of pollution are important factors in 
reducing cardiovascular risk. Also, avoiding negative 
psychological stress thus reducing raised FFA concen-
trations and spikes of concentration of FFA in the blood 
is also very important.
Within the framework here presented, it is exceedingly
important for the prevention of CVD and its acute
episodes with the timely knowledge of blood pH, FFA,
and albumin concentrations in the blood, which togeth-
er with the ratio between these last two values allow us
to understand the degree of risk for a cardiovascular
event.
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